One AstraZeneca Investor Questions Logic of Any Gilead Deal

(Bloomberg) -- Although a mega-deal could help AstraZeneca Plc achieve its growth targets and provide cash to fund its pipeline, any merger with Gilead Sciences Inc. would face a number of question...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.